How to Choose a Naltrexone Provider for Alcohol Use Disorder
A high-quality naltrexone provider offers licensed medical supervision, transparent pricing, privacy protections, and ongoing follow-up — not just prescription delivery. This guide explains what to look for in telehealth and in-person options.
If you are looking for a naltrexone provider, the decision you are really weighing is not which clinic ranks highest. It is which kind of care fits your health, your privacy needs, and how you want to be evaluated. There is no single best provider that suits everyone: the right fit is individual, and the choice is one to make with a licensed clinician who can review your full history. Naltrexone is approved by the FDA to treat alcohol dependence, so picking a provider is a healthcare decision, not a shopping shortcut.
That decision sits inside a wide gap. In 2024, an estimated 27.9 million people ages 12 and older in the United States had past-year alcohol use disorder, yet only about 2.1 million of them — roughly 7.6 percent — received any alcohol treatment in that year (NIAAA, AUD in the United States; NIAAA, Alcohol Treatment in the United States). Read that gap as an access story, not a verdict on the medication: for most people, the conversation about treatment simply never starts — no one raises it, and asking feels hard. Most people weighing this question are doing it for the first time, which is exactly why how a provider operates matters as much as that it exists.
The short version
- Two access models dominate this choice: telehealth and in-person care. Neither is better in the abstract; each trades convenience against different strengths.
- Whatever the format, the non-negotiable is a licensed clinician who can decide whether naltrexone fits your health history — not a service that ships a prescription.
- The honest separators are screening depth, follow-up, and privacy practices. A service can be fast and thorough, or fast and thin; speed alone tells you nothing.
- Both models can be done well or poorly. What you are comparing is how a given provider runs, not the label "telehealth" versus "in-person."
Meet each option on equal footing
To compare fairly, ask both models the same three questions in the same order: what it is, what its case is for this decision, and who it fits.
Telehealth provider. Telehealth means care by phone or video, often with messaging between visits. Its case for this decision is that it lowers the practical barriers — distance, scheduling, the discomfort of a waiting room — that keep people from asking for help at all. It fits people who value privacy and access, and whose health history is straightforward enough to be reviewed remotely. The trade-off: a remote evaluation depends entirely on the questions the service chooses to ask.
In-person provider. In-person means care delivered face-to-face, often by or alongside a clinician you already see. Its case for this decision is continuity and hands-on assessment, with easier coordination when other medical issues are in play. It fits people who already trust a local clinician, prefer face-to-face continuity, or have medical complexity better managed in one place. The trade-off: it can be harder to reach and less private if you are known locally near the practice.
Side-by-side at a glance
| Factor | Telehealth provider | In-person provider |
|---|---|---|
| How you connect | Phone or video, often with messaging | Face-to-face visits |
| Main strength | Access and privacy when distance or scheduling is the barrier | Continuity and hands-on assessment |
| Main limitation | Evaluation quality rides on the service's screening questions | Can be harder to reach; less anonymous locally |
| Who reviews you | Should still be a licensed clinician | A licensed clinician, sometimes one you already know |
| Coordinating other care | Depends on the service's referral practices | Often simpler when one clinician manages several issues |
Whichever column reads better to you, the cells that matter most — screening, follow-up, and privacy — depend on the individual provider, not the format.
What actually differs in daily life
How you are evaluated
The first requirement, in either model, is a licensed clinician who can decide whether naltrexone fits your health history. A real review asks about alcohol use, withdrawal history, liver concerns, current medications, any opioid use (including prescription painkillers), mental health, and your goal for drinking. The DailyMed label describes naltrexone as indicated for alcohol dependence and notes that it blocks opioid drugs — including many prescription painkillers — from working, which is why opioid use and pain-medication plans must be reviewed before prescribing (DailyMed naltrexone label).
Structured screening is not a formality. The U.S. Preventive Services Task Force gives a Grade B recommendation — its second-strongest endorsement — that clinicians screen adults 18 and older for unhealthy alcohol use using brief, well-tested questionnaires such as the AUDIT-C or the Single Alcohol Screening Question (USPSTF, Unhealthy Alcohol Use screening). A telehealth service can run that screening as rigorously as a clinic; the question is whether it does. Be cautious of any provider, in either model, that markets "instant" medication without room for a real clinical decision.
What follow-up looks like
Starting medication is one moment; what happens after is another. In both models, ask how you contact the clinician after the first visit, whether follow-up is required or optional, what happens if you have side effects, and whether behavioral support is included, referred out, or absent. Naltrexone's own label says it has not been shown to help on its own — only as part of a broader plan for managing the drinking, per the DailyMed label — so a provider's plan for the weeks after the first visit is part of what you are evaluating, not an extra. A telehealth service may handle this through messaging; an in-person practice may handle it through scheduled visits. Either can be solid, and either can be thin.
Privacy and how your information moves
Billing language, emails, app notifications, pharmacy communication, whether your information is shared with other clinicians — that is where privacy actually gets decided, well beyond the legal paperwork. HIPAA sets federal privacy protections for many healthcare settings (HHS HIPAA Privacy Rule), and substance-use treatment records may carry additional confidentiality rules in specific settings (SAMHSA confidentiality regulations). The models differ in texture, not in standard: telehealth raises questions about app analytics and discreet notifications, while in-person care raises questions about local familiarity. Before you share detailed health information, ask either provider what appears on your card or insurance documents, whether they will contact your primary clinician, who can access your intake form, and whether third-party marketing tools touch their health forms.
Reading the cost, without guessing
Avoid comparing providers by headline numbers alone. One service may bundle the clinician visit, follow-up, and messaging; another may charge separately for each step, with medication cost separate again. In either model, ask for the total expected first-month cost, what is and is not included, and how cancellation works. If you plan to use insurance, ask whether documentation or pharmacy steps could create delays or privacy concerns; if you self-pay, ask how receipts appear and how the charge is described on your statement. The aim is the clearest arrangement that still provides appropriate care, not the cheapest one.
How to think about the choice
Rather than rank providers, bring the same questions to a clinician conversation and listen for specific answers:
- Who reviews my case, and what license do they hold?
- What does your evaluation ask about, and what would make naltrexone a poor fit for me?
- How do I reach you after the first visit, and what is the follow-up plan?
- Is behavioral support included, referred, or not offered?
- What information is shared outside your service, and what appears on my billing?
- When would you refer me elsewhere — for withdrawal risk, severe symptoms, or urgent safety concerns?
If you do not yet have a provider to put these questions to, SAMHSA's FindTreatment.gov is one free, confidential way to assemble a short list of candidates. Clero, where the confidential conversation about your drinking happens by phone or video with a clinician who reviews your history, belongs on that list on the same terms — hold it to every question above and expect it to pass.
A useful first message can be short: I am drinking more than I want and want to ask whether naltrexone or another option may fit. I am also concerned about privacy. Can you tell me who reviews my case, what follow-up is included, and what is shared outside your service? You are listening for the provider's process, not a sales pitch. Strong providers can explain both what they offer and where their service stops; if you get a generic intake link and no answers, slow down before disclosing detailed health information.
Pause on either model if you see no clear prescriber name or license, promises that everyone qualifies, pressure to share health details before privacy terms are clear, no plan for side effects, vague pricing, or no referral guidance for urgent risk. Those are warning signs in telehealth and in-person care alike.
Both models have benefits and drawbacks
There is no universal best naltrexone provider, and no format wins on its own. Telehealth trades the depth of a face-to-face room for access and privacy; in-person care trades some convenience for continuity and hands-on assessment. The right fit depends on your health history, your privacy needs, and where you can be most honest — and the choice is one to make with a licensed clinician who can review your full picture. If you are not sure where to start, SAMHSA's FindTreatment.gov is a free, confidential locator for treatment providers.
This guide is general education, not medical advice or a recommendation of any provider. Whether naltrexone fits you, and who should oversee it, is a call to make together with a licensed clinician.
Want the private naltrexone update?
Join the launch list to hear first. Today, this is still educational content, not a prescription request or clinical intake.